Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Kim
Peter J Neumann

Showing results (91-100 of 436) with videos related to

Pageof 44
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 4, 2019
Embracing the science of value in healthMurray Krahn, Stirling Bryan, Karen Lee, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2010
Does Medicare have an implicit cost-effectiveness threshold?James D Chambers, Peter J Neumann, Martin J Buxton
Pharmacoeconomics|October 7, 2009
30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvementPeter J Neumann, Chi-Hui Fang, Joshua T Cohen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value FrameworksJoshua T Cohen, Jordan E Anderson, Peter J Neumann
Health Affairs (Project Hope)|September 13, 2006
Biotechnology and Medicare's new technology policy: lessons from three case studiesPatricia Seliger Keenan, Peter J Neumann, Kathryn A Phillips
Clinical Orthopaedics and Related Research|January 24, 2007
Trends in cost effectiveness analyses in orthopaedic surgeryCarmen A Brauer, Peter J Neumann, Allison B Rosen
The American Journal of Managed Care|December 21, 2019
Outcome measures for oncology alternative payment models: practical considerations and recommendationsJakub P Hlávka, Pei-Jung Lin, Peter J Neumann
Health Services Research|June 4, 2021
Value-based drug pricing in the Biden era: Opportunities and prospectsPeter J Neumann, Daniel A Ollendorf, Joshua T Cohen
American Journal of Public Health|October 17, 2008
Measuring the value of public health systems: the disconnect between health economists and public health practitionersPeter J Neumann, Peter D Jacobson, Jennifer A Palmer
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2024
Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness AnalysesFeng Xie, Ting Zhou, Brittany Humphries, et al.
Pageof 44

Showing results (91-100 of 436) with videos related to

Sort By:
Pageof 44
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 4, 2019
Embracing the science of value in healthMurray Krahn, Stirling Bryan, Karen Lee, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2010
Does Medicare have an implicit cost-effectiveness threshold?James D Chambers, Peter J Neumann, Martin J Buxton
Pharmacoeconomics|October 7, 2009
30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvementPeter J Neumann, Chi-Hui Fang, Joshua T Cohen
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Three Sets of Case Studies Suggest Logic and Consistency Challenges with Value FrameworksJoshua T Cohen, Jordan E Anderson, Peter J Neumann
Health Affairs (Project Hope)|September 13, 2006
Biotechnology and Medicare's new technology policy: lessons from three case studiesPatricia Seliger Keenan, Peter J Neumann, Kathryn A Phillips
Clinical Orthopaedics and Related Research|January 24, 2007
Trends in cost effectiveness analyses in orthopaedic surgeryCarmen A Brauer, Peter J Neumann, Allison B Rosen
The American Journal of Managed Care|December 21, 2019
Outcome measures for oncology alternative payment models: practical considerations and recommendationsJakub P Hlávka, Pei-Jung Lin, Peter J Neumann
Health Services Research|June 4, 2021
Value-based drug pricing in the Biden era: Opportunities and prospectsPeter J Neumann, Daniel A Ollendorf, Joshua T Cohen
American Journal of Public Health|October 17, 2008
Measuring the value of public health systems: the disconnect between health economists and public health practitionersPeter J Neumann, Peter D Jacobson, Jennifer A Palmer
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 28, 2024
Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness AnalysesFeng Xie, Ting Zhou, Brittany Humphries, et al.
Pageof 44